PEARLS: Is Our Use of Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography Meaningful for Our Patients?

Clin Oncol (R Coll Radiol). 2022 Sep;34(9):589-592. doi: 10.1016/j.clon.2022.05.004. Epub 2022 May 29.

Authors

J R Murray¹, P Sankey², A C Tree³, E Hall⁴

Affiliations

¹ The Royal Marsden NHS Foundation Trust, Sutton, UK; The Institute of Cancer Research, London, UK. Electronic address: julia.murray@icr.ac.uk.
² University Hospitals Plymouth NHS Trust, Plymouth, UK.
³ The Royal Marsden NHS Foundation Trust, Sutton, UK; The Institute of Cancer Research, London, UK.
⁴ The Institute of Cancer Research, London, UK.

PMID: 35649963
DOI: 10.1016/j.clon.2022.05.004

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Male
Positron Emission Tomography Computed Tomography* / methods
Prostate
Prostate-Specific Antigen
Prostatic Neoplasms* / diagnostic imaging

Substances

Prostate-Specific Antigen

Grants and funding